These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20919532)

  • 1. [New concepts of pathogenesis, diagnosis, and treatment of neurodegenerative diseases].
    Ugriumov MV
    Vestn Ross Akad Med Nauk; 2010; (8):6-19. PubMed ID: 20919532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of preclinical diagnosis and preventive treatment of neurodegenerative diseases].
    Ugrumov MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(11):4-14. PubMed ID: 26978045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprevention: a new challenge?
    Corvol JC
    Rev Neurol (Paris); 2012 Nov; 168(11):796-801. PubMed ID: 22902171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are age-related neurodegenerative diseases linked with various types of magnesium depletion?
    Durlach J; Bac P; Durlach V; Durlach A; Bara M; Guiet-Bara A
    Magnes Res; 1997 Dec; 10(4):339-53. PubMed ID: 9513930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oxidative stress and antioxidants in neurodegenerative diseases.
    Rao AV; Balachandran B
    Nutr Neurosci; 2002 Oct; 5(5):291-309. PubMed ID: 12385592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going?
    Lewczuk P; Kornhuber J
    Expert Rev Proteomics; 2011 Aug; 8(4):447-58. PubMed ID: 21819301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegenerative Disorders of the Eye and of the Brain: A Perspective on Their Fluid-Dynamical Connections and the Potential of Mechanism-Driven Modeling.
    Guidoboni G; Sacco R; Szopos M; Sala L; Verticchio Vercellin AC; Siesky B; Harris A
    Front Neurosci; 2020; 14():566428. PubMed ID: 33281543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.
    Baldacci F; Mazzucchi S; Della Vecchia A; Giampietri L; Giannini N; Koronyo-Hamaoui M; Ceravolo R; Siciliano G; Bonuccelli U; Elahi FM; Vergallo A; Lista S; Giorgi FS; Hampel H
    Expert Rev Mol Diagn; 2020 Apr; 20(4):421-441. PubMed ID: 32066283
    [No Abstract]   [Full Text] [Related]  

  • 10. Exosome Biomarkers Revolutionize Preclinical Diagnosis of Neurodegenerative Diseases and Assessment of Treatment Responses in Clinical Trials.
    Kapogiannis D
    Adv Exp Med Biol; 2020; 1195():149. PubMed ID: 32468469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery.
    Wang X; Zhang JB; He KJ; Wang F; Liu CF
    Front Pharmacol; 2021; 12():713963. PubMed ID: 34335276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-Therapy.
    Metcalfe SM; Bickerton S; Fahmy T
    Curr Pharm Des; 2017; 23(5):776-783. PubMed ID: 27924726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult neurogenesis and neurodegenerative disease.
    Steiner B; Wolf S; Kempermann G
    Regen Med; 2006 Jan; 1(1):15-28. PubMed ID: 17465817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition.
    Milošević M; Arsić A; Cvetković Z; Vučić V
    Front Nutr; 2021; 8():688086. PubMed ID: 34422879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
    Berg D
    Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications.
    Akhtar RS; Stern MB
    Expert Rev Neurother; 2012 Dec; 12(12):1429-38. PubMed ID: 23237350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal IgG synthesis in patients with alterations in the neurochemical dementia diagnostics.
    Zimmermann R; Beck G; Knispel S; Maler JM; Weih M; Wiltfang J; Kornhuber J; Lewczuk P
    J Alzheimers Dis; 2010; 19(4):1199-203. PubMed ID: 20308786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Neurodegenerative Diseases From Gait Rhythm Through Time Domain and Time-Dependent Spectral Descriptors.
    Mengarelli A; Tigrini A; Fioretti S; Verdini F
    IEEE J Biomed Health Inform; 2022 Dec; 26(12):5974-5982. PubMed ID: 36074873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of presymptomatic and symptomatic stages of parkinsonism in mice.
    Ugrumov MV; Khaindrava VG; Kozina EA; Kucheryanu VG; Bocharov EV; Kryzhanovsky GN; Kudrin VS; Narkevich VB; Klodt PM; Rayevsky KS; Pronina TS
    Neuroscience; 2011 May; 181():175-88. PubMed ID: 21382448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Presymptomatic detection of Parkinson's disease].
    Berendse HW; Booij J; Stoffers D; Ponsen MM; Hijman R; Wolters ECh
    Tijdschr Gerontol Geriatr; 2002 Apr; 33(2):70-7. PubMed ID: 12012945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.